Skip to main content
Top
Published in: Archives of Virology 1/2019

01-01-2019 | Annotated Sequence Record

Complete genome sequence of C130_2, a novel myovirus infecting pathogenic Escherichia coli and Shigella strains

Authors: Domonkos Sváb, Linda Falgenhauer, Manfred Rohde, Trinad Chakraborty, István Tóth

Published in: Archives of Virology | Issue 1/2019

Login to get access

Abstract

The genome sequence of a novel virulent bacteriophage, named “ C130_2”, that is morphologically a member of the family Myoviridae is reported. The 41,775-base-pair double-stranded DNA genome of C130_2 contains 59 ORFs but exhibits overall low sequence similarity to bacteriophage genomes for which sequences are publicly available. Phylogenetic analysis indicated that C130_2 represents a new phage type. C130_2 could be propagated well on enterohemorrhagic Escherichia coli (EHEC) O157:H7 and other pathogenic E. coli strains, as well as on strains of various Shigella species.
Appendix
Available only for authorised users
Literature
12.
go back to reference Sambrook J, Maniatis T, Fritsch EF, Laboratory CSH (1987) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Sambrook J, Maniatis T, Fritsch EF, Laboratory CSH (1987) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
25.
go back to reference Marchès O, Ledger TN, Boury M et al (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50:1553–1567CrossRefPubMed Marchès O, Ledger TN, Boury M et al (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50:1553–1567CrossRefPubMed
Metadata
Title
Complete genome sequence of C130_2, a novel myovirus infecting pathogenic Escherichia coli and Shigella strains
Authors
Domonkos Sváb
Linda Falgenhauer
Manfred Rohde
Trinad Chakraborty
István Tóth
Publication date
01-01-2019
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 1/2019
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-4042-0

Other articles of this Issue 1/2019

Archives of Virology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine